Posted by Michael Wonder on 03 Sep 2016
Regulatory agencies should engage in drug pricing
23 August 2016 - Mazzucato argues that drug pricing policies “must be completely transparent, so that governments can negotiate for better value on behalf of their populations.”
She also observes that the US government never exercised its right to cap prices of drugs developed through publicly funded research. In Europe, the European Medicines …
